Company Active LTD

Company profile

Dnae Group Holdings Limited

Home | DNAe

DNAe is developing LiDia-SEQ, a direct-from-specimen platform that performs DNA sequencing on a microchip, to provide rapid, actionable information to clinicians.

CRN

04821572

Founded

2003

Age

Overview

Legal name

DNAE GROUP HOLDINGS LIMITED

Region

Unknown

Registered address

SCALE SPACE

58 WOOD LANE

LONDON

UNITED KINGDOM

W12 7RZ

Insolvency history

Corporate ownership

Updated 06 Jun 2026 16:52

Controls 3

Dnae Group Holdings Limited

No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

6 events

30 Sep

2026

Accounts due

Accounts Due

Next accounts due date

18 Jul

2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

04 Jul

2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec

2024

Accounts filed

Accounts

Last accounts made up date

10 Sep

2024

Accounts With Accounts Type Group

Accounts PDF pending

AA | Transaction MzQzNTA2MzIxOGFkaXF6a2N4 | Paper/PDF filed

Published 11 Sep 2024 06:28

04 Jul

2003

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards

First funded

2008

Funded years

2008, 2020

Age at first award

5 years

Projects

2020 Knowledge Transfer Partnership

Imperial College of Science, Technology and Medicine [The] and DNAe Group Holdings Limited

1 Oct 2020 to 29 Feb 2024

Awarded

Unknown

To develop a blood test-based molecular analysis technique for monitoring breast cancer patients for early evidence of recurrence of tumor DNA.

2008 Collaborative R&D Lead participant

Development and feasibility of a rapid point-of-care Silicon Nanosystem for the Prediction of Drug Response (SNP-DR)

1 Nov 2008 to 31 Oct 2010

Awarded

£286,010

Total cost £789,362

Awaiting Public Summary

Product types

Collaborative R&D Knowledge Transfer Partnership